InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Pizzuti Dana, Chief Med and Dev Officer. Director active across 1 companies, notably Crinetics Pharmaceuticals, Inc.. In total, 4 filings have been published. The latest transaction was filed on 1 December 2025 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations4 total
US$72,7935,000 shares@ US$14.55850.0016% mcap50.3% of flow
Common Stock
SEC:0001628280-25-055054·
€72,7935,000 shares@ €14.55850.0016% mcap25.1% of flow
Common Stock
SEC:0001628280-25-055054:0·
US$71,9705,000 shares@ US$14.3940.0016% mcap49.7% of flow
Common Stock
SEC:0001658247-25-000013·
€71,9705,000 shares@ €14.3940.0016% mcap24.9% of flow
Common Stock
SEC:0001658247-25-000013:0·
4 of 4 declarations
About Pizzuti Dana
Dana Pizzuti serves as Chief Medical and Development Officer at Crinetics Pharmaceuticals, Inc. She is responsible for overseeing the company's medical and development initiatives, contributing to the creation of innovative treatments for patients. Her expertise is crucial for the success of clinical projects.
